Cardiovascular Business: Chemotherapy could be damaging children’s heart cells, leading to problems later in life

Results published in the journal PLOS ONE show that 20% of children treated with drugs called anthracyclines go on to suffer heart failure later in life.

The research is conducted in the laboratory of Gregory Aune, MD, PhD, of the Department of Pediatrics and the Greehey Children’s Cancer Research Institute at UT Health San Antonio.

Read the story.


Share This Article!